EMAIL THIS PAGE TO A FRIEND

Clinical cancer research : an official journal of the American Association for Cancer Research

FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.


PMID 24634381

Abstract

The transcription factor Forkhead box protein M1 (FOXM1) plays critical roles in cancer development and progression. However, the regulatory role and underlying mechanisms of FOXM1 in cancer metabolism are unknown. In this study, we characterized the regulation of aerobic glycolysis by FOXM1 and its impact on pancreatic cancer metabolism. The effect of altered expression of FOXM1 on expression of glycolytic enzymes and tumor development and progression was examined using animal models of pancreatic cancer. Also, the underlying mechanisms of altered pancreatic cancer glycolysis were analyzed using in vitro molecular biology. The clinical relevance of aberrant metabolism caused by dysregulated FOXM1 signaling was determined using pancreatic tumor and normal pancreatic tissue specimens. We found that FOXM1 did not markedly change the expression of most glycolytic enzymes except for phosphoglycerate kinase 1 (PGK-1) and lactate dehydrogenase A (LDHA). FOXM1 and LDHA were overexpressed concomitantly in pancreatic tumors and cancer cell lines. Increased expression of FOXM1 upregulated the expression of LDHA at both the mRNA and protein level and elevated LDH activity, lactate production, and glucose utilization, whereas reduced expression of FOXM1 did the opposite. Further studies demonstrated that FOXM1 bound directly to the LDHA promoter region and regulated the expression of the LDHA gene at the transcriptional level. Also, elevated FOXM1-LDHA signaling increased the pancreatic cancer cell growth and metastasis. Dysregulated expression and activation of FOXM1 play important roles in aerobic glycolysis and tumorigenesis in patients with pancreatic cancer via transcriptional regulation of LDHA expression.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2100850
Anti-FOXM1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2100851
Anti-FOXM1 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB1412254
ANTI-FOXM1 antibody produced in mouse, clone 2H4, purified immunoglobulin, buffered aqueous solution
SAB1412255
ANTI-FOXM1 antibody produced in mouse, clone 2E2, purified immunoglobulin, buffered aqueous solution
SAB1412256
ANTI-FOXM1 antibody produced in mouse, clone 3E3, purified immunoglobulin, buffered aqueous solution
SAB1412277
ANTI-FOXM1 antibody produced in mouse, clone 1D3, purified immunoglobulin, buffered aqueous solution
AV39518
Anti-FOXM1 antibody produced in rabbit, affinity isolated antibody, lyophilized powder
HPA029974
Anti-FOXM1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA029976
Anti-FOXM1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1100050
Anti-LDHA (216-228) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1406077
Anti-LDHA antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV54777
Anti-LDHA antibody produced in rabbit, affinity isolated antibody
EHU124431 MISSION® esiRNA, esiRNA human FOXM1 (esiRNA1)
EMU016141 MISSION® esiRNA, esiRNA targeting mouse Foxm1 (esiRNA1)
SAB4100133
Monoclonal Anti-LDHA antibody produced in mouse, clone LDHA-C47, culture supernatant
O2751
Sodium oxamate, ≥98%
C2H2NO3Na